m-PEG7-Br

CAS No. 104518-25-4

m-PEG7-Br ( —— )

Catalog No. M26976 CAS No. 104518-25-4

m-PEG7-Br is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
50MG 26 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    m-PEG7-Br
  • Note
    Research use only, not for human use.
  • Brief Description
    m-PEG7-Br is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.
  • Description
    m-PEG7-Br is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.(In Vitro):PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins.
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    (HO)-1; Antifection; NF-κB; NO; NOS; Nrf2
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    104518-25-4
  • Formula Weight
    403.3
  • Molecular Formula
    C15H31BrO7
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    COCCOCCOCCOCCOCCOCCOCCBr
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Myung DB, et al. Hydrangenol Isolated from the Leaves of Hydrangea serrata Attenuates Wrinkle Formation and Repairs Skin Moisture in UVB-Irradiated Hairless Mice. Nutrients. 2019 Oct 2;11(10):2354.
molnova catalog
related products
  • Alendronic Acid

    Alendronic acid is a nonhormonal medication?used for osteoporosis osteogenesis imperfecta and several other bone diseases.

  • Alpha-calcium ketogl...

    Alpha-calcium ketoglutarate monohydrate is the calcium salt form of Alpha-ketoglutarate, which is involved in the tricarboxylic acid cycle in organisms.

  • Remimazolam

    Remimazolam is a benzodiazepine derivative drug as an alternative to the short-acting imidazobenzodiazepine midazolam, for use in induction of anaesthesia and conscious sedation for minor invasive procedures.?Remimazolam was found to be both faster acting and shorter lasting than midazolam, and human clinical trials showed a faster recovery time and predictable, consistent pharmacokinetics, suggesting some advantages over existing drugs for these applications.?